PA Expands, MindMed's Win, Alcohol Impact & Netherlands Trial | Trade To Black

Welcome back to the Trade To Black Podcast powered by the Benzinga network. Shadd Dales, Anthony Varrell and Benjamin A. Smith start by taking a look at the fierce competition between legal flower and alcohol. TD Cowen's note predicts significant shifts, with this gaining 18 million consumers in the next 5 years while alcohol loses 2 million. We talk about how changing consumer habits and legal access impact revenue growth trends in states with legalized flower. Discussing the ongoing trial in the Netherlands, authorities are moving towards full legalization. Specifically we touch on the misconceptions surrounding legality in the country, the four-year trial's goals, and the impact it could have on reducing criminal involvement and antisocial behavior. We then shift over to Pennsylvania's legislature. It passes a bill with potential game-changing consequences for cultivators and dispensaries. We take a look at the details on Senate Bill 773, awaiting Governor Josh Shapiro's signature, and how it aims to increase freedom for growers and independent dispensaries. There could be implications of reduced dispensary permits and a temporary moratorium on license transfers. Lastly, MindMed reports positive results for its Phase 2b clinical trial of MM-120 in generalized anxiety disorder (GAD). We will take a look at the findings as MM-120 demonstrates significant improvements compared to placebo. To see more videos of the Trade To Black Podcast click the following: https://www.youtube.com/playlist?list=PLni0KRSCoiAceKtb9z2IdnnmFiVS-ZdpW Subscribe to our newsletter: https://landing.mailerlite.com/webforms/landing/i2l8u5 Add us on: Facebook: https://www.facebook.com/TheDalesReport Twitter: https://twitter.com/TheDalesReport Instagram: https://www.instagram.com/dalesreport Website: https://thedalesreport.com/ The information provided in this video is for educational purposes only and should not be considered as financial or investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. The Dales Report Inc. disclosure policy applies to this video: https://thedalesreport.com/disclosure/ In accordance with an executed agreement between The Dales Report and the aforementioned entity, highlighted either directly or indirectly in the article, The Dales Report has been engaged for a stipulated contractual duration with the purpose of publicly disseminating information pertaining to the aforementioned entity via The Dales Report’s media assets, encompassing its website, diverse social media platforms, and YouTube channel. Compensation for our services involves the receipt of a predefined monetary consideration, which may encompass ordinary shares in instances where monetary compensation was not obtained. In such instances where share compensation was received, The Dales Report hereby asserts the right to engage in the acquisition or disposition of such shares subsequent to the conclusion of the aforementioned contractual period, in compliance with provincial, state, and federal securities regulations.